From: Dibenzazecine compounds with a novel dopamine/5HT2A receptor profile and 3D-QSAR analysis
Compound
AHAD11
B157
LERU301
SH3
pK i (hD1)
5.82 ± 0.07
6.98 ± 0.05
7.26 ± 0.03
6.17 ± 0.04